secwatch.observer — SEC 8-K summary
======================================

Issuer:     ARTELO BIOSCIENCES, INC. (ARTL)
CIK:        0001621221
Form:       8-K
Filed at:   2023-08-08T23:59:59+00:00
Accession:  0001640334-23-001479
Event type: other_material
Sentiment:  neutral
Materiality: 0.20
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Artelo Biosciences increases CEO base salary to $500,000
--------------------------------------------------------

- CEO Gregory D. Gorgas annual base salary raised from $475,000 to $500,000 effective August 4, 2023.
- Target bonus remains unchanged at 50% of base salary subject to performance objectives.
- Compensation Committee approved the increase; no other officer compensation changes disclosed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1621221/000164033423001479/0001640334-23-001479-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1621221/000164033423001479/artl_8k.htm
  HTML page:      https://secwatch.observer/filing/0001640334-23-001479

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer